Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating IncomePreferred Dividend PaymentsProfit After TaxRevenueShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

cbdMD (YCBD) EPS (Weighted Average and Diluted) (2017 - 2025)

cbdMD's EPS (Weighted Average and Diluted) history spans 8 years, with the latest figure at $0.19 for Q2 2024.

  • For Q2 2024, EPS (Weighted Average and Diluted) rose 116.38% year-over-year to $0.19; the TTM value through Jun 2024 reached -$1.61, up 25.12%, while the annual FY2021 figure was -$0.47, 267.86% down from the prior year.
  • EPS (Weighted Average and Diluted) for Q2 2024 was $0.19 at cbdMD, up from -$1.35 in the prior quarter.
  • Across five years, EPS (Weighted Average and Diluted) topped out at $0.4 in Q1 2020 and bottomed at -$1.74 in Q1 2023.
  • The 5-year median for EPS (Weighted Average and Diluted) is -$0.2 (2020), against an average of -$0.39.
  • The largest annual shift saw EPS (Weighted Average and Diluted) crashed 2850.0% in 2022 before it soared 116.38% in 2024.
  • A 5-year view of EPS (Weighted Average and Diluted) shows it stood at -$0.18 in 2020, then tumbled by 94.44% to -$0.35 in 2021, then tumbled by 57.14% to -$0.55 in 2022, then plummeted by 110.91% to -$1.16 in 2023, then skyrocketed by 116.38% to $0.19 in 2024.
  • Per Business Quant, the three most recent readings for YCBD's EPS (Weighted Average and Diluted) are $0.19 (Q2 2024), -$1.35 (Q1 2024), and -$1.16 (Q2 2023).